Platinum-based chemotherapy - Globe Thesis

Keyword [Platinum-based chemotherapy] Result: 21 - 40 \| Page: 2 of 5
21.	The Prognostic Impact Of Expressions Of Nm23-H1 And Livin On Advanced Carcinoma Of Stomach Patients Treated With Platinum-Based Chemotherapy
22.	Influence Of XRCC1 And XPD Gene Polymorphisms On Outcome Of Platinum-based Chemotherapy For Advanced Non Small Cell Lung Cancers
23.	Association Of CYP1A1 Polymorphisms With Lung Cancer Risk And MIF Regulating Cell Cycle Pathway Genes Polymorphisms With The Clinical Outcomes Of Platinum-based Chemotherapy In Advanced Non-small-cell Lung Cancer
24.	Polymorphisms Of Base Excision Repair Gene And Sensitivity To Platinum-based Chemotherapy In Advanced Non-small Cell Lung Cancer
25.	Relationship Between The Expression Of IGF-IR And Response To Platinum-based Chemotherapy As Well As Prognosis In Advanced Non-small Cell Lung Cancer
26.	Clinical Study On Treatment Of Non - Small Cell Lung Cancer With Phlegm Syndrome By Combination Of Erchen Decoction And Platinum - Based Chemotherapy
27.	Correlation Analysis Of Abcc2, The Abcb1 And Abcg2 Gene Polymorphism And Lung Cancer, Platinum Chemotherapy
28.	Association Between Polymorphisms Of ERCC1 And XPD And Sensitivity To Platinum-based Chemotherapy In Advanced Non-small Cell Lung Cancer
29.	Genetic Polymorphisms Of XPA,XPC And XRCC1 Are Correlated With The Prognosis Of Non-small-cell Lung Cancer Patients Treated With Platinum-based Chemotherapy
30.	ERCC1mRNA Expression Is Associated With Clinical Outcome Of Non-small Cell Lung Cancer Treated With Platinum-based Chemotherapy
31.	Targeting DNA Repair Pathway In The Treatment Of Breast Cancer:Preclinical And Clinical Study
32.	Genome-Wide Association Study Of Prognosis And Toxicity In Non-Small Cell Lung Cancer Patients Receiving Platinum-based Chemotherapy
33.	Clinical Research On "Shenrong" Decoction Attenuating The Toxicity Of Platinum-Based Chemotherapy In Treating Advanced Non-Small-Cell Lung Cancer
34.	Insulin-like Growth Factor Receptor Gene Polymorphism And Susceptibility As Well As Platinum-based Chemotherapy Outcomes To Non-small Lung Cancer
35.	3DRT/IMRT With Concurrent Gefitinib In Non-small Cell Lung Cancer Patients After Failure Of Platinum-based Chemotherapy:Dose Escalation Study And Translational Reasearch
36.	Relationship Between Polymorphisms Of RR37and Sensitivity To Platinum Based Chemotherapy (GP Scheme) In Patients With Advanced Non-Small Cell Lung Cancer
37.	Association Of Single Nucleotide Polymorphism In DNA Repair Gene With The Clinical Outcome To Platinum-based Chemotherapyin Epithelial Ovarian Cancer
38.	DNA Repair Capacity In Peripheral Blood Lymphocytes Predicts Efficacy Of Patients With Gastric Cancer Treated With Platinum-based Chemotherapy
39.	Expressions Of ERCC1and FANCD2and Clinical Outcomes Of Platinum-based Chemotherapy In Completely Resected NSCLC
40.	The Associated Between The Polymorphisms Of XPG Gene And The Clinical Outcome Of Epithelial Ovarian Cancer Patients With Platinum-based Chemotherapy
<<First <Prev Next> Last>> Jump to